What is the dosage of Cefdnir (Cefdinir) for acute pharyngitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosage for Acute Pharyngitis

For acute pharyngitis caused by Group A Streptococcus (GAS), cefdinir should be administered at 14 mg/kg once daily (maximum 600 mg) or 7 mg/kg twice daily (maximum 300 mg per dose) for 10 days. 1

Dosing Recommendations

Pediatric Patients (6 months through 12 years)

  • Once-daily dosing: 14 mg/kg once daily for 10 days (maximum 600 mg per day) 1
  • Twice-daily dosing: 7 mg/kg twice daily for 10 days (maximum 300 mg per dose) 1
  • Once-daily dosing has been shown to be as effective as twice-daily dosing for pharyngitis 1, 2

Adolescents and Adults

  • Once-daily dosing: 600 mg once daily for 10 days 1, 2
  • Twice-daily dosing: 300 mg twice daily for 10 days 1, 2

Clinical Evidence and Rationale

Cefdinir is an oral third-generation cephalosporin with good activity against common respiratory pathogens, including Group A Streptococcus (GAS), which is the most common bacterial cause of acute pharyngitis 3. According to the FDA-approved labeling, cefdinir is indicated for the treatment of pharyngitis/tonsillitis caused by Streptococcus pyogenes 1.

Clinical studies have demonstrated that:

  • Cefdinir administered once or twice daily for 10 days is effective for GAS pharyngitis 2
  • In comparative trials, cefdinir showed superior bacterial eradication rates (91.4% for once-daily and 91.7% for twice-daily dosing) compared to penicillin V (83.4%) 2
  • Clinical cure rates were also higher with cefdinir (94.8% for once-daily and 96.3% for twice-daily) compared to penicillin V (88.9%) 2

Important Considerations

Position in Treatment Algorithm

  • While cefdinir is effective for GAS pharyngitis, the Infectious Diseases Society of America (IDSA) guidelines recommend penicillin or amoxicillin as first-line therapy due to their narrow spectrum, infrequency of adverse reactions, and modest cost 4
  • Cefdinir should be considered for penicillin-allergic patients who are not anaphylactically sensitive to penicillin 4
  • The FDA has approved cefdinir for a 5-day course of therapy for GAS pharyngitis, but the IDSA guidelines note that many studies of short-course cephalosporin therapy lack strict entry criteria and assessment of compliance 4

Dosing in Special Populations

  • Renal impairment: For patients with creatinine clearance <30 mL/min, the dose should be reduced to 7 mg/kg (up to 300 mg) once daily 1
  • Hemodialysis patients: Initial dose of 300 mg or 7 mg/kg every other day, with an additional dose after each hemodialysis session 1

Common Side Effects

  • Diarrhea is the most common adverse event with cefdinir 2, 5
  • In clinical trials, diarrhea occurred more frequently with cefdinir than with comparator agents 5
  • Despite higher rates of diarrhea, discontinuation rates due to adverse events were generally similar between cefdinir and comparator groups 6

Practical Administration Tips

  • Cefdinir may be administered without regard to meals 1
  • The oral suspension must be shaken well before each administration and can be stored at room temperature for up to 10 days after reconstitution 1
  • The palatability of cefdinir oral suspension has been reported to be superior to other antimicrobial agents, which may enhance adherence in pediatric patients 3, 6

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.